All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-33381105

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	33381105	D144A	S	S	Carcinoma, Hepatocellular	G R S I L	View
2	33381105	D144E	S	S	Carcinoma, Hepatocellular	G R S I L	View
3	33381105	D144G	S	S	Carcinoma, Hepatocellular	G R S I L	View
4	33381105	G130N	S	S	Carcinoma, Hepatocellular	G R S I L	View
5	33381105	G130R	S	S	Carcinoma, Hepatocellular	G R S I L	View
6	33381105	G145A	S	S	Carcinoma, Hepatocellular	G R S I L	View
7	33381105	I126N	S	S	Carcinoma, Hepatocellular	G R S I L	View
8	33381105	K141E	S	S	Carcinoma, Hepatocellular	G R S I L	View
9	33381105	K141I	S	S	Carcinoma, Hepatocellular	G R S I L	View
10	33381105	M133I	S	S	Carcinoma, Hepatocellular	G R S I L	View
11	33381105	M133L	S	S	Carcinoma, Hepatocellular	G R S I L	View
12	33381105	P120L	S	S	Carcinoma, Hepatocellular	G R S I L	View
13	33381105	P120Q	S	S	Carcinoma, Hepatocellular	G R S I L	View
14	33381105	P120S	S	S	Carcinoma, Hepatocellular	G R S I L	View
15	33381105	P142L	S	S	Carcinoma, Hepatocellular	G R S I L	View
16	33381105	P142S	S	S	Carcinoma, Hepatocellular	G R S I L	View
17	33381105	Q129H	S	S	Carcinoma, Hepatocellular	G R S I L	View
18	33381105	Q129N	S	S	Carcinoma, Hepatocellular	G R S I L	View
19	33381105	S143L	S	S	Carcinoma, Hepatocellular	G R S I L	View
20	33381105	T126N	S	S	Carcinoma, Hepatocellular	G R S I L	View
21	33381105	A1762T	BCP		Carcinoma, Hepatocellular	G R S L	View
22	33381105	C1653T	EnhII		Carcinoma, Hepatocellular	G R S L	View
23	33381105	G1764A	BCP		Carcinoma, Hepatocellular	G R S L	View
24	33381105	T1753V	BCP		Carcinoma, Hepatocellular	G R S L	View
25	33381105	G145R	S	S	Carcinoma, Hepatocellular	G R S I L	View
26	33381105	I126S	S	S	Carcinoma, Hepatocellular	G R S I L	View
27	33381105	M133T	S	S	Carcinoma, Hepatocellular	G R S I L	View
28	33381105	Q129R	S	S	Carcinoma, Hepatocellular	G R S I L	View
29	33381105	T126S	S	S	Carcinoma, Hepatocellular	G R S I L	View
30	33381105	A181T	RT	P	Carcinoma, Hepatocellular	D G R S L	View
31	33381105	A181V	RT	P	Carcinoma, Hepatocellular	D G R S L	View
32	33381105	L180M	RT	P	Carcinoma, Hepatocellular	D G R S L	View
33	33381105	M204I	RT	P	Carcinoma, Hepatocellular	D G R S L	View
34	33381105	M204V	RT	P	Carcinoma, Hepatocellular	D G R S L	View
35	33381105	M250V	RT	P	Carcinoma, Hepatocellular	D G R S L	View
36	33381105	N236T	RT	P	Carcinoma, Hepatocellular	D G R S L	View
37	33381105	S202G	RT	P	Carcinoma, Hepatocellular	D G R S L	View
38	33381105	S202I	RT	P	Carcinoma, Hepatocellular	D G R S L	View
39	33381105	T184G	RT	P	Carcinoma, Hepatocellular	D G R S L	View
40	33381105	T184S	RT	P	Carcinoma, Hepatocellular	D G R S L	View
41	33381105	I126A	S	S	Carcinoma, Hepatocellular	G R S I L	View
42	33381105	P120T	S	S	Carcinoma, Hepatocellular	G R S I L	View
43	33381105	T126A	S	S	Carcinoma, Hepatocellular	G R S I L	View
44	33381105	T143L	S	S	Carcinoma, Hepatocellular	G R S I L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.